Type 2 diabetes mellitus and colorectal cancer risk: Is homocysteine the missing link? [17]

American Journal of Gastroenterology

Volumn 102, Issue 2, 2007, Pages 466-467

  Phelip, Jean Marc ^a   Roblin, Xavier ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; SOMATOMEDIN C;

AMINO ACID BLOOD LEVEL; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; DNA METHYLATION; HIGH RISK PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HOMOCYSTEINE; HUMANS; RISK FACTORS;

EID: 33846516821     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00904_17.x     Document Type: Letter

References (13)

1. Limburg PJ, Vierkant RA, Fredericksen ZS, et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: A population-based, retrospective cohort study. Am J Gastroenterol 2006;101:1872-9.
2. Elwing JE, Gao F, Davidson NO, et al. Type 2 diabetes mellitus: The impact on colorectal adenoma risk in women. Am J Gastroenterol 2006;101:1866-71.
3. Martos R, Valle M, Morales R, et al. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children. Metabolism 2006;55:72-7.
4. Cho NH, Lim S, Jang HC, et al. Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: A 4-year prospective study. Diabetes Care 2005;28:2750-5.
5. Pufulete M, Al-Ghnaniem R, Leather AJ, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003;124:1240-8.
6. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66.
7. Kim YI. Nutritional epigenetics: Impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 2005;135:2703-9.
8. Kochanek S, Toth M, Dehmel A, et al. Interindividual concordance of methylation profiles in human genes for tumor necrosis factors alpha and beta. Proc Natl Acad Sci U S A 1990;87:8830-4.
9. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolater eductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 2002;99:5606-11.
10. Goelz SE, Vogelstein B, Hamilton SR, et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985;228:187-90.
11. Gloria L, Cravo M, Pinto A, et al. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 1996;78:2300-6.
12. Munkholm P. Review article: The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18(suppl):2:1-5.
13. Roblin X, Phelip JM, Ducros V, et al. Hyperhomocysteinemia, folate deficiency and carcinogenesis in IBD patients. Gastroenterology 2006;130(suppl 2):A200.